Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 24, 2017 (9 years ago)

PONSTEL (Mefanamic Acid)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981

Recalling firm
Shionogi Inc.
Origin
GA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0982-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Shionogi Inc.

All 2017 recalls
Class III · Low risk

Mefenamic Acid

Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

Terminated Dissolution failure Shionogi Inc. NDC 66993-070-30 D-0981-2017
Class III · Low risk

Mefenamic Acid Capsules

Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules

Terminated Particulate / foreign matter Shionogi Inc. NDC 66993-070-30 D-0219-2018

Other dissolution failure recalls from 2017

All dissolution failure recalls
Class II · Moderate risk

Dutasteride and Tamsulosin HCl Capsules

Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.

Terminated Dissolution failure Teva Pharmaceuticals USA NDC 0591-3771-30 D-0069-2018